Retinal Degeneration Fund

Funding rounds backed by Retinal Degeneration Fund.

Export CSV
Funding disclosed in full
$190M
Median round
$190M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Osanni Bio

Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model

$190MSeries BBiotechUnited States
4 participantsHorowitz GroupInvus OpportunitiesPatient Square CapitalRetinal Degeneration Fund